Stock Events

Stock Events

Karyopharm Therapeutics (25K.F) Q4 2024 Earnings

5NovConfirmed

Q4 2023

Q2 2024

Q3 2024

Q4 2024

-0.31

-0.27

-0.23

-0.18

Details

Expected EPS

-0.2411975832

Actual EPS

-0.238576

Surprise EPS

0

Surprise Percent

+1.09%

Description

Karyopharm Therapeutics (25K.F) has reported earnings of -0.238576 per share for Q4 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.